Bunge Global SA

Bunge Global SA (BG) Stock Analysis

$115.480

+4.042 (+3.50%)At close

Loading chart…
High
115.880
Open
113.000
VWAP
114.39
Vol
1.58M
Mkt Cap
15.24B
Low
111.795
Amount
180.35M
EV/EBITDA, TTM
7.08

Bunge Global SA is an agribusiness solutions company. The Company is engaged in the processing of oil seeds and the production and supply of specialty vegetable oils and fats. Its segments include Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. The Soybean Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of soybean and soybean related products, as well as biodiesel and fertilizer production and distribution. The Softseed Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, refining, marketing, and sale of soft seeds (canola/rapeseed, sunflower seed, and safflower seed) and soft seed related products, as well as biodiesel production and distribution.

www.bunge.com

AI analysis of Bunge Global SA (BG)

buy

Bunge Global SA (BG) is a strong buy right now due to its impressive recent performance and positive outlook. The current price is $115.48, which is significantly below the analyst price target of $150 from Barclays, indicating a potential upside of 29.9%. Additionally, the company reported a remarkable Q2 revenue of $24.04 billion, an 88.3% year-on-year increase, which exceeded analyst expectations. However, a risk to consider is the recent decline in net margin, which fell to 2.94% in Q2 2026, down from 4.65% in Q4 2024, indicating potential profitability concerns.

Valuation Metrics

The current forward P/E ratio for Bunge Global SA (BG) is 14.53, compared to its 5-year average forward P/E of 10.17.

Forward P/E

Strongly Overvalued
5Y Average P/E
10.17
Current P/E
14.53
Overvalued
12.23
Undervalued
8.11

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
7.95
Current EV/EBITDA
7.08
Overvalued
10.32
Undervalued
5.57

Forward P/S

Fair
5Y Average P/S
0.23
Current P/S
0.23
Overvalued
0.26
Undervalued
0.20

Alphio AI Price Scenarios for BG

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%BG

$80.30

Scenario price

B

Base

Base · 50%BG

$76.33

Scenario price

B

Bear

Bear · 25%BG

$69.92

Scenario price

Whales holding BG

G

Greenwich Wealth Management, LLC

+ HoldingBG

+6.57%

3M Return

H

Horizon Kinetics Holding Corporation

+ HoldingBG

+2.43%

3M Return

C

Cinctive Capital Management LP

+ HoldingBG

+2.26%

3M Return

P

Punch & Associates Investment Management, Inc.

+ HoldingBG

+1.32%

3M Return

BG FAQ — answered by Alphio AI

Bunge Global SA is an agribusiness solutions company. The Company is engaged in the processing of oil seeds and the production and supply of specialty vegetable oils and fats. Its segments include Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. The Soybean Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of soybean and soybean related products, as well as biodiesel and fertilizer production and distribution. The Softseed Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, refining, marketing, and sale of soft seeds (canola/rapeseed, sunflower seed, and safflower seed) and soft seed related products, as well as biodiesel production and distribution. It operates in the Consumer Non-Cyclicals sector (FATS & OILS industry).

Bunge Global SA (BG) is a strong buy right now due to its impressive recent performance and positive outlook. The current price is $115.48, which is significantly below the analyst price target of $150 from Barclays, indicating a potential upside of 29.9%. Additionally, the company reported a remarkable Q2 revenue of $24.04 billion, an 88.3% year-on-year increase, which exceeded analyst expectations. However, a risk to consider is the recent decline in net margin, which fell to 2.94% in Q2 2026, down from 4.65% in Q4 2024, indicating potential profitability concerns.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started